Otonomy Announces Publication of Phase 1/2 Trial Results Showing Tinnitus Improvement in Patients Receiving OTO-313

Back to Jobs

Results published in Otology & Neurotology, a leading journal in field OTO-313 was well-tolerated and demonstrated a statistically significant higher proportion of responders than placebo across consecutive visits (Weeks 4 and 8) Patient enrollment in Phase 2 trial is ongoing with results expected

Apply Now